Shares of GoodRx Holdings Inc. GDRX, +7.31% fell more than 3% in the extended session Thursday after the health-care company reported adjusted earnings that were above Wall Street expectations but guided for lower first-quarter sales. GoodRx said it lost $298.3 million, or 74 cents a share, in the fourth quarter, contrasting with earnings of $15.2 million, or 4 cents a share, in the fourth quarter of 2019. It pinned the swing to losses mostly on a $296.7 million year-over-year increase in stock-based compensation expenses and associated payroll taxes connected with its initial public offering. Adjusted for that and other one-time items, GoodRX earned $32.2 million, or 8 cents a share. Revenue rose to $154 million, from $113 million a year ago. Analysts polled by FactSet had expected adjusted earnings of 7 cents a share on sales of $147.8 million. The company guided for first-quarter revenue between $158 million and $161 million, and a full-year 2021 revenue between $735 million and $755 million. The analysts surveyed by FactSet expect first-quarter sales around $162 million. The stock ended the regular trading day up 7.3%.
View Article Origin Here
